Your search returned 160 results.

Sort
Results
101.
Lacrimal gland and nasolacrimal duct uptake on I-124 PET/CT imaging. MedStar authors:
  • Burman, Kenneth D
  • Kulkarni, Kanchan P
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2019
Citation:
  • 2019/04/30/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Wu D, Kulkarni K, Burman K, Wartofsky L, Van Nostrand D.
Local accession number:
  • C2019_108
102.
Localization of parathyroid adenoma with 4D CT in patients with inconclusive findings on traditional imaging modalities. MedStar authors:
  • Felger, Erin
  • Kulkarni, Kanchan P
  • Papoian, Vardan
  • Rosen, Jennifer E
  • Smith, Loui
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Nuclear Medicine
  • Radiology
  • Surgery/Endocrine Surgery
  • Surgery/General Surgery
Form of publication:
  • Poster Presentation
All authors:
  • Felger E
  • Kulkarni K
  • Papoian V
  • Rosen J.
  • Smith L
Local accession number:
  • B2018141
103.
Poor compliance for continuous sialogogues in patient-reported surveys. MedStar authors:
  • Burman, Kenneth D
  • Kulkarni, Kanchan P
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman K
  • Kharazi P
  • Khorjekar G
  • Kulkarni K
  • Moreau S
  • Van Nostrand D.
  • Wartofsky L
  • Wu D
Local accession number:
  • B2018215
104.
Evaluation of the relationship of reproductive hormones to radioiodine breast uptake in patients with differentiated thyroid cancer: a pilot study. MedStar authors:
  • Kulkarni, Kanchan P
  • Kumar, Anagha
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Kulkarni K
  • Kumar A
  • Van Nostrand D.
  • Wu D
Local accession number:
  • B201870
105.
Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer. MedStar authors:
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Hobbs R
  • Brown T
  • Byard J
  • Plyku D
  • Sgouros G
  • Van Nostrand D.
  • Wu D
Local accession number:
  • B201872
106.
New use for an old isotope. MedStar authors:
  • Burman, Kenneth D
  • Gomes Lima, Christiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
  • Ylli, Dorina
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman K
  • Gomes Lima C
  • Van Nostrand D.
  • Wartofsky L
  • Wu D
  • Ylli D
Local accession number:
  • B201874
107.
Mitotane as a novel agent for the treatment of aggressive thyroid cancer. MedStar authors:
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Wartofsky, Leonard
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • MedStar Georgetown University Hospital Residents
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A
  • Burman K
  • Costello J
  • Jensen K
  • Patel A
  • Vasko V.
  • Wartofsky L
Local accession number:
  • B201875
108.
Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer. MedStar authors:
  • Burman, Kenneth D
  • Garcia, Carlos A
  • Kulkarni, Kanchan P
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Kulkarni K
  • Burman K
  • Garcia C
  • Van Nostrand D.
  • Wartofsky L
  • Wu D
Local accession number:
  • B201889
109.
The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: a systematic review and meta-analysis. MedStar authors:
  • Burman, Kenneth D
  • Heimlich, Layla
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2018
Citation:
  • 2018/04/30/
Department:
  • Library
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Heimlich SL
  • Burman K
  • Van Nostrand D.
  • Wartofsky L
  • Wu D
Local accession number:
  • B201890
110.
Whole body retention of I-131 at 24hr vs. 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors:
  • Atkins, Frank
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Endocrinology
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Atkins F, Van Nostrand D, Orquiza M, Wartofsky L
Local accession number:
  • 2013_158
111.
124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G
Local accession number:
  • 2013_166
112.
#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Duong E, Orquiza M, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_159
113.
Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Duong E, Orquiza M, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_233
114.
The utility of "Blind" 131 I treatment for differentiated thyroid cancer: an educational exhibit. MedStar authors:
  • Elboga, Umut
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D
Local accession number:
  • 2013_160
115.
Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Endocrinology
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L
Local accession number:
  • 2013_165
116.
Characterization of Sialoadenitis (SA) after administration of continuous Sialogogues (SGs) during the day and night after 131I therapy (tx). MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
Local accession number:
  • 2013_230
117.
Whole body retention of 131I at 24hr versus 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors:
  • Atkins, Frank
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
Local accession number:
  • 2013_231
118.
The Utility of "Blind" 131I treatments for differentiated thyroid cancer: an educational exhibit. MedStar authors:
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D
Local accession number:
  • 2013_234
119.
Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_161
120.
Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Department of Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_162
121.
Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_235
122.
Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Citation:
  • 2013/06/08/
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G
Local accession number:
  • 2013_236
123.
Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth D
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Moreau, Shari
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L
Local accession number:
  • 2014.1_132
124.
Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Orquiza, Michael H
  • Schneider, M
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
Local accession number:
  • 2014.1_133
125.
Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Kulkarni, Kanchan
  • Orquiza, Michael H
  • Schneider, M
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Endocrinology
  • Medicine/General Internal Medicine
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D
Local accession number:
  • 2014.1_134
126.
The use of diuretics for increasing radioiodine (RAI) uptake in patients with well-differentiated thyroid cancer MedStar authors:
  • Orquiza, Michael H
  • Van Nostrand, Douglas
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Orquiza M, Van Nostrand D
Local accession number:
  • 2014.1_135
127.
Detection of 131I in public places: a national survey. MedStar authors:
  • Orquiza, Michael H
  • Van Nostrand, Douglas
Year: 2014
Citation:
  • Unknown 2014 Jun 7
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Van Nostrand D,Orquiza M, Bloom G
Local accession number:
  • 2014.1_131
128.
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer (DTC) - organ dosimetry MedStar authors:
  • Atkins, Francis
  • Van Nostrand, Douglas
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Plyku D, Hobbs FR, Srinivasan S, Atkins F, Van Nostrand D, Sgouros G
Local accession number:
  • 2015_188
129.
How should one measure and how low should the urinary iodine excretion be prior to radioiodine imaging and/or therapy in patients with differentiated thyroid cancer? An educational exhibit MedStar authors:
  • Bethancourt, E
  • Burman, Kenneth D
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bethancourt E, Moreau S, Guan H, Burman K, Wartofsky L, Van Nostrand D
Local accession number:
  • 2015_189
130.
The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors:
  • Bethancourt, E
  • Bikas, A
  • Burman, Kenneth D
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
Local accession number:
  • 2015_190
131.
The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors:
  • Bethancourt, E
  • Bikas, A
  • Burman, Kenneth D
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
Local accession number:
  • 2015_191
132.
Assessment of serial complete blood counts following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors:
  • Bikas, A
  • Boyle, Lisa M
  • Burman, Kenneth D
  • Desale, Sameer
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Mar 9
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A, Burman K, Desale S, Mete M, Boyle L, Wartofsky L, Van Nostrand D
Local accession number:
  • 2015_75
133.
Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors:
  • Bikas, A
  • Burman, Kenneth D
  • Desale, Sameer
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2015
Citation:
  • Unpublished 2015 Mar 5
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A, Burman K, Desale S., Mete M, Wartofsky L, Van Nostrand D
Local accession number:
  • 2015_207
134.
The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer MedStar authors:
  • Bethancourt, E
  • Burman, Kenneth D
  • Garcia, Carlos
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wexler, Jason
Year: 2015
Citation:
  • Unpublished 2015 Jun
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Garcia CA, Van Nostrand D, Wexler JA, Bethancourt E, Burman k, Wartofsky l
Local accession number:
  • 2015_192
135.
Assessment of serial comprehensive metabolic Panel ats following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors:
  • Bikas, Athanasios
  • Boulougoura, Afroditi
  • Burman, Kenneth D
  • Mirza, Faryal
  • Vachhani, Shivangi
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2016
Citation:
  • Unpublished 2016/03/14
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A, Boulougoura A, Mirza F, Vachhani S, Wartofsky L, Van Nostrand D, Burman K
Local accession number:
  • 2016_51
136.
Glucose concentration modulates the efficacy of treatment with metformin in medullary thyroid cancer cells MedStar authors:
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Wartofsky, Leonard
Year: 2016
Citation:
  • Unpublished 2016/03/14
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A, Jensen K, Patel A, Costello J, Wartofsky L, Burman K, Vasko V
Local accession number:
  • 2016_53
137.
Assessment of the role of cytochrome C oxidase subunit 4 (COX4) in differentiated thyroid cancer MedStar authors:
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Wartofsky, Leonard
Year: 2016
Citation:
  • Unpublished 2016/03/14
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A, Jensen K, Patel A, Costello J, Wartofsky L, Burman K, Vasko V
Local accession number:
  • 2016_55
138.
Does pretreatment with lithium prior to radioactive iodine (RAI) therapy improve outcome in patients with metastatic differentiated thyroid cancer (DTC)? MedStar authors:
  • Burman, Kenneth D
  • Gomes Lima, Christiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 20172016
Citation:
  • Unpublished 2017/04/01
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Auh S
  • Breymaier M
  • Burman KD
  • Cochran C
  • et al.
  • Gomes-Lima CJ
  • Klubo-Gwiezdzinska J
  • Van Nostrand D
  • Wartofsky L
Local accession number:
  • A2017_312
139.
Frequency, duration and severity of salivary effects in DTC patients with onset at 7 weeks to 3 months after I-131 therapy: an analysis of the Thyca National Survey. MedStar authors:
  • Gomes Lima, Christiane J
  • Mete, Mihriye
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wu, Di
Year: 20172016
Citation:
  • Unpublished 2017/04/01
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Gomes Lima CJ
  • Hall JP
  • Khorjekar G
  • McIver B
  • Mete M
  • Van Nostrand D
  • Wu D
Local accession number:
  • A2017_313
140.
Frequency, duration and severity of salivary side effects in DTC patients with onset at 3 to 12 months after I-131 therapy: an analysis of the Thyca National Survey. MedStar authors:
  • Gomes Lima, Christiane J
  • Mete, Mihriye
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wu, Di
Year: 20172016
Citation:
  • Unpublished 2017/04/01
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Gomes Lima CJ
  • Hall JP
  • Khorjekar G
  • McIver B
  • Mete M
  • Van Nostrand D
  • Wu D
Local accession number:
  • A2017_314
141.
A new method to help determine whether a +Tg/-Dx scan patient with differentiated thyroid cancer may benefit from a dosimetrically-guided I-131 therapy. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Christiane J
  • Kulkarni, Kanchan P
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 20172016
Citation:
  • Unpublished 2017/04/01
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman K
  • Gomes Lima CJ
  • Kulkarni K
  • Van Nostrand D
  • Wartofsky L
  • Wu D
Local accession number:
  • A2017_315
142.
I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study. MedStar authors:
  • Atkins, Frank
  • Brown, Taneshea A
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wu, Di
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Atkins FB
  • Brown TA
  • Frey EC
  • Lodge MA
  • Moreau SL
  • Plyku D
  • Van Nostrand D
  • Wu D
Local accession number:
  • A2017_004
143.
Rapid wash out: comparison of Primary (pHPTH) versus Secondary Hpth (sHPTH) and utility of dual radiopharmaceutical acquisition with 99mtc-sestamibi and 123I for tumor localization. MedStar authors:
  • Kulkarni, Kanchan P
  • Sharma, Shiksha
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Kulkarni K
  • Sharma S
Local accession number:
  • A2017_042
144.
A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey. MedStar authors:
  • Brennan, Michael T
  • Hall, Jordan
  • Khorjekar, Gauri
  • Van Nostrand, Douglas
  • Wu, Di
  • Zeymo, Alexander
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bloom G
  • Brennan MT
  • Hall J
  • Khorjekar G
  • McIver B
  • Van Nostrand D
  • Wu D
  • Zeymo A
Local accession number:
  • A2017_050
145.
Brain metastases from differentiated thyroid carcinoma: current therapies and outcomes. MedStar authors:
  • Burman, Kenneth D
  • Deeb, Hala
  • Gomes-Lima, Christiane J
  • Hritani, Rama
  • Mete, Mihriye
  • Punukollu, Sree
  • Rao, Sarika
  • Van Nostrand, Douglas
  • Wu, Di
  • Zeymo, Alexander
Year: 2017
Citation:
  • Unpublished 2017/10/18
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman K
  • Deeb H
  • Gomes-Lima C
  • Hritani R
  • Jonklaas J
  • Mete M
  • Punukollu S
  • Rao S
  • Van Nostrand D
  • Wu D
  • Zeymo A
Local accession number:
  • A2017_568
146.
Xerophthalmia and epiphora secondary to 131I therapy in patients with differentiated thyroid cancer: a prospective study. MedStar authors:
  • Burman, Kenneth D
  • Orquiza, Michael
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2017
Citation:
  • Unpublished 2017/10/18
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman K
  • Orquiza M
  • Turner D
  • Van Nostrand D
  • Wartofsky L
  • Wu D
Local accession number:
  • A2017_569
147.
Prognostic factors in the overall survival rate of patients with differentiated thyroid cancer bone metastasis. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Christiane J
  • Kulkarni, Kanchan P
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
  • Zeymo, Alexander
Year: 2017
Citation:
  • Unpublished 2017/10/18
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman KD
  • Gomes-Lima C
  • Kulkarni K
  • Moreau S
  • Van Nostrand D
  • Wartofsky L
  • Wu D
  • Zeymo A
Local accession number:
  • A2017_570
148.
Low-iodine diet and urine iodine measurements for 131-I treatments in patients with differentiated thyroid cancer: a comparison of 18 clinical practice guidelines. MedStar authors:
  • Burman, Kenneth D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
Year: 2017
Citation:
  • Unpublished 2017/10/18
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman KD
  • Turner D
  • Van Nostrand D
  • Wartofsky L
  • Wu D
Local accession number:
  • A2017_571
149.
Pretreatment with lithium may be associated with improved overall survival in patients undergoing dosimetry-based radioactive iodine treatment (RAI) for metastatic differentiated thyroid cancer. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Christiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2017
Citation:
  • Unpublished 2017/10/18
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Auh S
  • Burman KD
  • Cochran C
  • et al.
  • Gomes-Lima C
  • Luo H
  • Tobey A
  • Van Nostrand D
  • Wartofsky L
  • Zemskova M
Local accession number:
  • A2017_572
150.
Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells. MedStar authors:
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Costello, John
  • Wartofsky, Leonard
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A
  • Burman K
  • Costello J
  • Jensen K
  • Patel A
  • Vasko V
  • Wartofsky L
Local accession number:
  • A2017_058
151.
The role of autophagy regulator LC3B in thyroid cancer cells response to metabolic stress and radiation. MedStar authors:
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Costello, John
  • Wartofsky, Leonard
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Bikas A
  • Burman K
  • Costello J
  • Jensen K
  • Patel A
  • Tkavc R
  • Vasko V
  • Wartofsky L
Local accession number:
  • A2017_059
152.
Overall survival rate of patients with differentiated thyroid cancer bone metastasis. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Christiane J
  • Kulkarni, Kanchan P
  • Moreau, Shari L
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
  • Zeymo, Alexander
Year: 2017
Citation:
  • Unpublished 2017/10/03
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Poster Presentation
All authors:
  • Burman KD
  • Gomes-Lima CJ
  • Kulkarni K
  • Moreau SL
  • Van Nostrand D
  • Wartofsky L
  • Wu D
  • Zeymo A
Local accession number:
  • A2017_074
153.
Poor patient compliance with instructions for continuous sialogogues after <sup>131</sup> I therapy. MedStar authors:
  • Burman, Kenneth D
  • Kulkarni, Kanchan
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 30169900
Year: 2019
Citation:
  • Oral Diseases. 25(1):158-163, 2019 Jan.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Kharazi P, Khorjekar G, Kulkarni K, Moreau S, Van Nostrand D, Wartofsky L, Wu D
154.
Brain Metastases From Differentiated Thyroid Carcinoma: Prevalence, Current Therapies, and Outcomes. MedStar authors:
  • Aulisi, Edward
  • Burman, Kenneth D
  • Deeb, Hala
  • Gomes-Lima, Cristiane J
  • Hritani, Rama
  • Jonklaas, Jacqueline
  • Mete, Mihriye
  • Punukollu, Sree
  • Rao, Sarika N
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
  • Zeymo, Alexander
PMID:
  • 30706042
Year: 2019
Citation:
  • Journal of the Endocrine Society. 3(2):359-371, 2019 Feb 01.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Internal Medicine
  • Medicine/Nuclear Medicine
  • Neurosurgery
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aulisi EF, Burman KD, Deeb H, Gomes-Lima CJ, Hritani R, Jonklaas J, Mete M, Punukollu S, Rao SN, Van Nostrand D, Wartofsky L, Wu D, Zeymo A
155.
I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response. MedStar authors:
  • Garcia, Carlos
  • Plyku, Donika
  • Van Nostrand, Douglas
  • Wu, Di
PMID:
  • 35119623
Year: 2022
Citation:
  • Annals of Nuclear Medicine. 36(3):213-223, 2022 Mar.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Garcia C, Hobbs RF, Plyku D, Sgouros G, Van Nostrand D, Wu D
156.
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. MedStar authors:
  • Burman, Kenneth D
  • Klubo-Gwiezdzinska, Joanna
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 22313411
Citation:
  • Thyroid. 22(3):310-7, 2012 Mar.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Comparative Study
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Jonklaas J, Klubo-Gwiezdzinska J, Mete M, Van Nostrand D, Wartofsky L
157.
Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Mete, Mihriye
  • Moreau, Shari
  • O'Neil, Jeff
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 24820222
Citation:
  • Thyroid. 24(9):1394-9, 2014 Sep.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L
158.
Current treatment modalities for spinal metastases secondary to thyroid carcinoma. [Review] MedStar authors:
  • Boyle, Lisa M
  • Burman, Kenneth D
  • Carroll, Nancy M
  • Kushchayeva, Yevgeniya
  • Van Nostrand, Douglas
  • Wexler, Jason
PMID:
  • 24827757
Citation:
  • Thyroid. 24(10):1443-55, 2014 Oct.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • Surgery
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Boyle LM, Burman KD, Carroll NM, Kushchayev SV, Kushchayeva YS, Preul MC, Sonntag VK, Teytelboym OM, Van Nostrand D, Wexler JA
159.
Spinal metastases due to thyroid carcinoma: an analysis of 202 patients. MedStar authors:
  • Boyle, Lisa M
  • Burman, Kenneth D
  • Carroll, Nancy M
  • Felger, Erin A
  • Kushchayeva, Yevgeniya
  • Van Nostrand, Douglas
PMID:
  • 24921429
Citation:
  • Thyroid. 24(10):1488-500, 2014 Oct.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • Surgery
  • Surgery/Endocrine Surgery
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bonichon F, Boyle LM, Burman KD, Carroll NM, Felger EA, Kushchayev SV, Kushchayeva YS, Links TP, Preul MC, Sonntag VK, Teytelboym OM, Van Nostrand D
160.
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 30900516
Year: 2019
Citation:
  • Thyroid. 29(4):461-470, 2019 04.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Fuhrer D, Giovanella L, Greenspan B, Hegedus L, Luster M, Muylle K, Smit JWA, Tuttle RM, Van Nostrand D, Verburg FA
Pages

Powered by Koha